Marina Talamonti - Concepedia

Author

Marina Talamonti

Also Known As

G. Tonini, M S Talamonti, M Talamonti, M. S. Talamonti, M. Talamonti, M., Talamonti, M.S. Talamonti, Marina Talamonti, Mark S Talamonti, Mark S. Talamonti

327

Publications

14.3K

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Policlinico Tor Vergata Sapienza University of Rome Università Cattolica del Sacro Cuore University of L'Aquila

About

Marina Talamonti is an author at University of Rome Tor Vergata specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	601
2	Health Sciences	3	3	64
3	Allergy	3	3	106
4	Engineering	1	1	19
5	Social Sciences	1	1	23

Marina Talamonti

Publications

Citations

H-Index

Page 1

	Year	Citations
Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab Marina Talamonti, E. Botti, Marco Galluzzo, British Journal of Dermatology	2013	143
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics Marina Papoutsaki, Maria Sole Chimenti, Antonio Costanzo, Journal of the American Academy of Dermatology RheumatologyAutoimmune DiseaseMedicineRheumatic DiseasesSevere Psoriasis	2007	124
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study Cataldo Patruno, Maddalena Napolitano, Giuseppe Argenziano, Journal of the European Academy of Dermatology and Venereology	2020	94
Quality of Life and Psychological Impact in Patients with Atopic Dermatitis Marina Talamonti, Marco Galluzzo, Dionisio Silvaggio, Journal of Clinical Medicine	2021	80
Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study Marco Galluzzo, Lorenzo Tofani, Alessandra Petruzzellis, Journal of Clinical Medicine	2020	77
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations Paolo Gisondi, Marina Talamonti, Andrea Chiricozzi, Dermatology and Therapy	2021	68
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation Marco Galluzzo, Marina Talamonti, Clara De Simone, Expert Opinion on Biological Therapy	2018	65
Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis Marco Galluzzo, Marina Talamonti, Arnaldo Cioni, Journal of Clinical Medicine Il-23 InhibitorGenital PsoriasisAllergyAutoimmune DiseaseDifficult-to-treat Areas	2022	61
Role of the <i>HLA-C*06</i> allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients Marina Talamonti, Marco Galluzzo, J.M. van den Reek, British Journal of Dermatology	2017	58
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study Cataldo Patruno, Gabriella Fabbrocini, G. Longo, American Journal of Clinical Dermatology Elderly PatientsAtopic DermatitisAllergy MedicineContact DermatitisOutcomes Research	2021	57

Page 1